QA: Summit Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001599298_2024_Summit_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001599298, Summit Therapeutics Inc

  xvar xval
0 AssetsCurrent 189,712,000
1 IntangibleAssetsNetIncludingGoodwill 1,893,000
2 PropertyPlantAndEquipmentNet 204,000
3 remainder_Assets 11,140,000
4 LiabilitiesCurrent 20,405,000
5 LiabilitiesNoncurrent 4,852,000
6 remainder_Liabilities 100,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,586,842
9 ResearchAndDevelopmentExpense 60,105,649
10 remainder_Expenses 3,081,907,921
11 remainder_Revenues -6,904,673
12 remainder_NetIncome -4,234,210
13 remainder_ComprehensiveNetIncome -925,961
  yvar yval
0 Assets 202,949,000
1 Liabilities 125,257,000
2 Expenses 3,173,600,412
3 Revenues -6,904,673
4 StockholdersEquity 77,692,000
5 NetIncome -3,184,739,295
6 ComprehensiveNetIncome -3,185,202,276
7 BaseVar 1,756,935,628
8 EconomicCapitalRatiobeforeLimitedLiability -18.4
9 EconomicCapitalRatio 0.00000000000260

Edgar->Model Mapping

Feature Distribution

Change over Time